News & Events

Biomedicine and Biotechnology

April 13, 2016

Stephen Johnston, Ph.D., Professor and Co-director, Biodesign Center for Innovations in Medicine; Hugh Mason, Ph.D., Associate Professor, Biodesign Center for Infectious Diseases and Vaccinology; and Carlo Maley, Ph.D., Associate Professor, Virginia G. Piper Biodesign Center for Personalized Diagnostics. The ASU School of Life Sciences is presenting this seminar.  

International collaboration reaches milestone in curating new resource for unraveling human disease

February 25, 2016

Gene bank collection now totals 80 percent of all human protein-coding genes, collaboration reports An international collaboration of organizations, including Arizona State University’s Biodesign Institute and the Dana-Farber Cancer Institute, has reached a milestone in creating a library of complete genetic blueprints for the thousands of different proteins in human cells, called the human proteome. The collection – consisting of open-reading frames (ORFs), the portions of genes that...

BioPolicy Summit tackles reproducibility of science issues

February 11, 2016

To err is human, even for one of the most number crunching, rigorous and truth seeking of all activities: science. The issue of errors in science --- irreproducible research --- was recently a focal point for a national discussion when the Global Biological Standards Institute (GBSI) hosted its 2016 BioPolicy Summit. The 2016 GBSI Summit—“Research Reproducibility: Innovative Solutions to Drive Quality” welcomed premiere life science thought leaders, including Arizona State University...

LaBaer featured panelist at BioPolicy Summit on research reproducibility

February 2, 2016

ASU Biodesign Institute interim executive director Dr. Joshua LaBaer, MD, PhD, will be headed to the nation's capital next week to participate in an esteemed panel of top bioscience leaders as part of the 2016 Global BioPolicy Summit.  On Tuesday, February 9, at 12:00 noon EST, Global Biological Standards Institute (GBSI) will host its 2016 BioPolicy Summit at the Newseum in Washington, DC. The 2016 Summit—Research Reproducibility: Innovative Solutions to Drive Quality welcomes LaBaer...

ASU names LaBaer interim executive director of the Biodesign Institute

January 13, 2016

Dr. Joshua L. LaBaer, a leading researcher in cancer and personalized medicine, has been named interim executive director for the Biodesign Institute at Arizona State University.   “LaBaer’s leadership will ensure that we continue our progress toward establishing the Biodesign Institute as a world-class research institute focused on solving key societal challenges in health, sustainability and national security,” said Sethuraman Panchanathan, senior vice president of ASU’s Office...

New ASU worldwide resource for exploring genes’ hidden messages

December 11, 2015

After a decade-long $3 billion international effort, scientists heralded the 2001 completion of the human genome as a moon landing achievement for biology and the key to finally solving intractable diseases like cancer. But it turns out this was only the end of the beginning, with a much greater complexity to life revealed by the roughly 20,000 genes found within the human genome. For one, most diseases are incredibly complex, with very few caused by a single gene mutation. Rather, the more...

ASU, Mayo Clinic collaborate to advance medicine through joint research

December 1, 2015

2016 seed-grant recipients announced Arizona State University, in partnership with Mayo Clinic in Arizona, has announced the recipients of the 2016 ASU-Mayo Seed Grant Program. The program funds critical joint research projects in the health field led by scientists from both ASU and Mayo Clinic. The awardees this year are making innovative strides in the treatment of cancer, Alzheimer’s, Parkinson’s, heart failure and infectious diseases, as well as advancing nanobody technology and...

Biodesign’s Anderson named Health Care Hero

August 25, 2015

The Phoenix Business Journal has named ASU Biodesign Institute and Mayo Clinic cancer researcher Karen Anderson, M.D., Ph.D., a Health Care Hero and presented her with its annual top doctor honor, the 2015 Physician Award. Anderson’s front-line work in oncology is leading a momentous shift to better match treatments based on each patient’s unique genetic profile, called precision medicine. At ASU’s Biodesign Institute, Anderson and her colleagues are developing new ways to diagnose...

What are you going to do about it?

April 21, 2015

“You folks are doing fabulous, world-changing work here.” -Jude LaCava   Guest blogger and local Fox10 sportscaster Jude LaCava shares with us his personal story of how he became involved in supporting game-changing Biodesign cancer research.    by Jude LaCava I live in a world of games as a sports reporter.  Covering athletic contests is like covering the toy department of life. But my passion is what really matters in life and that is life...

Surveying telltale signs of ovarian cancer

March 12, 2015

This year, ovarian cancer will claim over 125,000 lives worldwide. The deadly disease remains the fifth leading cause of cancer-related mortality in U.S. women, killing about 15,000 per year.  While diagnostic screening has long been a watchword, efforts to identify the disease in its early stages often fail. By the time ovarian cancer is detected, it has typically progressed to an advanced phase, where the 5-year survival rate falls below 30 percent.  Josh LaBaer, MD, PhD., and...